PeptideDB

ALDH1A3-IN-3 18962-05-5

ALDH1A3-IN-3 18962-05-5

CAS No.: 18962-05-5

ALDH1A3-IN-3 (compound 16) is a potent inhibitor of ALDH1A3 with IC50 of 0.26 μM. ALDH1A3-IN-3 is also a substrate of A
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

ALDH1A3-IN-3 (compound 16) is a potent inhibitor of ALDH1A3 with IC50 of 0.26 μM. ALDH1A3-IN-3 is also a substrate of ALDH3A1. ALDH1A3-IN-3 may be used in prostate cancer research.

Physicochemical Properties


Molecular Formula C10H12O2
Molecular Weight 164.2011
Exact Mass 164.084
CAS # 18962-05-5
PubChem CID 250077
Appearance Liquid
Density 1.036
Boiling Point 108-110 °C (5 mmHg)
Flash Point 108-110°C/5mm
Vapour Pressure 0.00982mmHg at 25°C
Index of Refraction 1.545-1.547
LogP 2.286
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 2
Rotatable Bond Count 3
Heavy Atom Count 12
Complexity 135
Defined Atom Stereocenter Count 0
SMILES

O(C1C([H])=C([H])C(C([H])=O)=C([H])C=1[H])C([H])(C([H])([H])[H])C([H])([H])[H]

InChi Key WDANSDASCKBVKH-UHFFFAOYSA-N
InChi Code

InChI=1S/C10H12O2/c1-8(2)12-10-5-3-9(7-11)4-6-10/h3-8H,1-2H3
Chemical Name

4-propan-2-yloxybenzaldehyde
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. J Med Chem. 2022 Mar 10;65(5):3833-3848.


Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~609.01 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (15.23 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (15.23 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 6.0901 mL 30.4507 mL 60.9013 mL
5 mM 1.2180 mL 6.0901 mL 12.1803 mL
10 mM 0.6090 mL 3.0451 mL 6.0901 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.